TerminatedPhase 2NCT05289570

Voxelotor for Improving Oxygen Saturation in Adults

Studying Adult acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Duke University
Principal Investigator
Ian Welsby, MD
Duke University
Intervention
Voxelotor(drug)
Enrollment
3 enrolled
Eligibility
18 years · All sexes
Timeline
20222023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05289570 on ClinicalTrials.gov

Other trials for Adult acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Adult acute respiratory distress syndrome

← Back to all trials